Profil Institute Allies with Antaros Medical
The Profil Institute for Clinical Research and Antaros Medical have collaborated to apply a broad range of non-invasive PET/MRI imaging techniques into pre- and postmarketing studies of cardiometabolic drugs and drug candidates.
The Profil Institute for Clinical Research and Antaros Medical have collaborated to apply a broad range of non-invasive PET/MRI imaging techniques into pre- and postmarketing studies of cardiometabolic drugs and drug candidates. The two companies plan to jointly design and conduct single and multi-center clinical studies.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
How the NIMBLE Study Supported Adherence With Quarterly Dosing of CemdisiranSeptember 18th 2025
Everything to Know About FDA’s Push Towards Radical Transparency in 2025September 17th 2025
IQVIA and Veeva Join Forces to Improve Efficiency and Patient OutcomesSeptember 17th 2025
Managing Background Therapies in the NIMBLE Phase III TrialSeptember 17th 2025
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
